Latest News

New sensor innovations in robotics position NVE to capture emerging spintronics opportunities, though near-term headwinds in medical and defense remain.

Government consulting firm Booz Allen Hamilton (NYSE:BAH) will be reporting results this Friday before the bell. Here’s what to expect. Booz Allen Hamilton m...

Gorman-Rupp (NYSE:GRC) manufactures and sells pumps globally will be announcing earnings results this Friday before market open. Here’s what you need to know...

WAVE Life Sciences (NASDAQ:WVE) outlined progress across its obesity-focused siRNA program and RNA editing pipeline during a Chardan discussion, with President and CEO Paul Bolno emphasizing the company’s chemistry platform, upcoming clinical studies and regulatory alignment for its alpha-1 antitryp

Commercial banking company Preferred Bank (NASDAQ:PFBC) will be reporting earnings this Friday morning. Here’s what to look for. Preferred Bank met analysts’...

Regional banking company Flagstar Financial (NYSE:FLG) will be reporting results this Friday before market open. Here’s what to look for. Flagstar Financial ...

Automotive safety systems provider Autoliv (NYSE:ALV) will be reporting results this Friday before market hours. Here’s what investors should know. Autoliv b...

Pricing discipline and operational efficiency are compounding faster than cost inflation, a rare mix that protects long-term returns.

What would it take for these six next-generation tech stocks to double?

Three structural shifts in chip design are forcing semiconductor makers to order significantly more manufacturing equipment.

Although neither Travelers nor Chubb is cheap today, strong operating results may interest growth-minded investors.

Lower unit costs from AI-powered content processing are strengthening profit margins as engagement scales across Meta's social platforms.

Amazon's operating cash flow towers over Target, but valuation multiples tell a different story.

Nuclear power is in the spotlight, but these two stocks have tumbled over the past year. Here's which sold-off stock is a better buy right now.

Rani Therapeutics (NASDAQ:RANI) outlined progress for its oral biologics delivery platform, including plans to advance its obesity program RT-114 and expectations for additional milestones from its collaboration with Chugai. Chief Executive Officer Talat Imran said the clinical-stage biotechnology

Structural cost discipline is lifting margins even as the company invests in growth, a dynamic that underpins confidence in accelerating free cash flow.

Arista boasts a high profit margin and zero debt, while CrowdStrike just reported its best quarter in history because of AI.

Telus (TSX:T) stock might be a falling knife, but the shares still look like a dividend deal going into November 2026.

Brookfield Renewable offers a 5.6% yield and targets 10%+ FFO growth. Here is what management said, plus risks every Canadian income investor should weigh.

Defense sales plunged 95%, but first-half revenue surged 36% on distributor strength.

Record net interest income and expanded margins drove sequential earnings growth.

Solid-state battery maker launches 100 MWh mass production line targeting 2028.

Gross margins dipped to 52.8%, but management expects recovery within two quarters as pricing actions take hold.

With their reliable cash flows, consistent dividend growth, and strong long-term growth prospects, these three TSX stocks could help investors build a sustainable stream of passive income.

A non-bank lender paying monthly dividends, including year-end special dividends, is tailor-made for a TFSA.